Safety warning for ADHD drug
The drug, a selective noradrenaline reuptake inhibitor indicated for both paediatric and adult treatment of ADHD, should be used with caution in patients with underlying medical conditions that could be exacerbated by these
side-effects, the TGA said.
Eli Lilly medical director Dr Greg van Wyk has faxed GPs saying recent analysis of combined data from controlled and uncontrolled clinical trials has indicated that increased blood pressure and heart rate could represent a risk
for some patients.
Atomoxetine was contraindicated in patients with symptomatic cardiovascular disease or moderate to severe hypertension, the TGA said.
It should also be used with caution in patients with congenital or acquired QT prolongation or a family history of QT prolongation.
“Patients should be screened for pre-existing or underlying cardiovascular or cerebrovascular conditions before initiation of treatment with atomoxetine, and